to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.
Fusion Proteins, bcr-abl
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Proto-Oncogene Proteins c-abl
High-Throughput Screening of Tyrosine Kinase Inhibitor Resistant Genes in CML.
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
Leukemia Myelogenous Chronic